Autolus Therapeutics Receives PRIME Designation From EMA For AUTO1 For The treatment Of Adult ALL
Autolus Therapeutics Highlights Updated Manufacturing Facility Strategy For Commercial Supply Of AUTO1
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2021
Autolus Therapeutics Cut to Neutral From Buy by Redburn
Redburn Downgrades Autolus Therapeutics to Neutral
Autolus Therapeutics analyst ratings
Autolus Therapeutics Reports Fy20 EPS $(2.76) Up From $(2.88) YoY
智通港美股会议日历|3月4日
隔夜要闻:纳指周跌1.6% 比特币总市值突破1万亿美元
Autolus Therapeutics Raises $100M Via Equity